Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.16 USD | +9.85% | +8.86% | -46.43% |
05-15 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.43% | 587M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+3.06% | 22.58B | |
-14.64% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Cabaletta Bio, WuXi Advanced Therapies Expand Manufacturing Deal to Include CABA-201